Funny Allergy Quotes, Jokes, Stories and a List of Crazy Reactions.
If you're looking for funny allergy quotes, jokes and stories you've come to the right place. I asked my readers from facebook to provide me with their experiences they've had regarding crazy allergy reactions and they did not let me down. They relayed dozens of incidents they've experienced through the years. Over the years I've discovered several funny allergies myself, including allergies to prednisone, diet products and the color red. Some patients have dozens of allergies. My experience is that most of these allergies are not allergies in the physiological sense. The te...
Source: The Happy Hospitalist - July 2, 2013 Category: Internists and Doctors of Medicine Authors: Tamer Mahrous Source Type: blogs
Lipogaine for Men: Look at the label
Lipogaine for Men may be a beauty best seller on Amazon.com but it may also have one of the worst names ever. It sounds like it should be a liposuction weight loss product but it’s actually supposed to prevent hair loss. Let’s look at the label to see what makes it work.
Lipogaine for Men: Intensive Treatment & Complete Solution for Hair Loss Ingredients
Water, propylene glycol, ethanol
These three ingredients are the solvents for the active ingredient.
Minoxidil 5%
Speaking of active ingredients here’s what makes this product really work. It’s the same drug ingredient used in the more popular R...
Source: thebeautybrains.com - June 22, 2013 Category: Consumer Health News Authors: thebeautybrains Tags: Questions Source Type: blogs
Does crushing up and mixing prenatal vitamins into shampoo really help hair?
Huang says….I’ve just finished reading The Beauty Aisle Insider (greeeat book btw!), and now I have a new unanswered question! I learned via your book the interesting fact that the hair we see and feel is not alive, so that got me to thinking about previously hearing some folks rave about crushing up prenatal vitamins and mixing it into their shampoo. Given the hair is dead, I don’t imagine it is making much use of this added nutrition, yet people still seem to be seeing a benefit. What gives?
The Beauty Brains respond:
Hi Huang! Thanks for the kind words about our book. (And if anyone else out there would li...
Source: thebeautybrains.com - June 13, 2013 Category: Consumer Health News Authors: thebeautybrains Tags: Questions Source Type: blogs
Phosphate Additives Promote Hardening of the Arteries
In this study subjects who were allowed to eat only the foods supplied by the researchers were, for four weeks, fed a control diet free of any phosphate additives. Then, for the next four weeks, they were fed a diet that contained the identical amount of calories, protein, fat, and carbohydrate as the control diet but this diet was made up of foods containing inorganic phosphate additives, like American cheese, soda, and processed meats.The report explains, "The average phosphorus content of the daily menu was 979 mg during the control period and 2124 mg during the test period." After a month of eating the foods with the a...
Source: Diabetes Update - June 7, 2013 Category: Diabetes Authors: Jenny Source Type: blogs
The AbbVie Culture Change Continues: 100 Scientists Will Be Laid Off
Less than a month after AbbVie quietly disclosed that its chief scientific officer is unexpectedly retiring (see this), the drugmaker is now shaking up R&D and will layoff approximately 100 scientists from its pain discovery program in neuroscience, according to sources. And an AbbVie spokesman confirmed the move.
The R&D changes, which the spokesman says will also involve adding some 90 jobs in such therapeutic categories as dermatology, gastroenterology and renal, are part of a larger transformation that AbbVie is undergoing after being split off earlier this from Abbott Laboratories (ABT).
Faced with patent expi...
Source: Pharmalot - May 30, 2013 Category: Pharma Commentators Authors: esilverman Source Type: blogs
How Much?! AbbVie Raises Niaspan Price Despite Study Failures
Over the past two years, two studies showed the Niaspan cholesterol drug did not benefit patients. Yet AbbVie has managed to maintain revenue generated by the pill using a simple business proposition – the drugmaker has consistently raised its price, Bloomberg News writes. And the tactic is drawing criticism at a time of rising health care costs and ongoing debate over prescription drug prices.
The Abbott Laboratories now charges $4.78 per pill, up from $3.50 two years ago, a 37 percent increase. “I don’t know how you can justify it,” Robert Giugliano, a cardiologist at Brigham and Women’s Hospital in Boston a...
Source: Pharmalot - May 24, 2013 Category: Pharma Commentators Authors: esilverman Source Type: blogs
Gouging 101 - AbbVie takes some heat for raising price of Niaspan after
studies panned it
When studies of AbbVie's chloesterol drug Niaspan raised questions about its effectiveness, analysts suggested it would lose its blockbuster status. But in the face of falling sales, AbbVie's former parent Abbott Laboratories ($ABT) simply raised the price. According to Bloomberg, recent spinoff AbbVie ($ABBV) boosted the price of cholesterol drug Niaspan 37%, offsetting unit sales losses after two studies showed it had little, if any, effect as a heart disease treatment. Niaspan raises HDL, or good cholesterol, and is often given along with drugs that lower bad cholesterol. AbbVie d...
Source: PharmaGossip - May 24, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs
Self-Managing Cholesterol
By David Spero
As a recent study indicates, reducing LDL (“bad" cholesterol) can help prevent complications in most people with diabetes. Why is LDL cholesterol a bad thing, and how do you get to a healthy level?
First, what is cholesterol? Discovered in 1769 by analyzing gallstones, cholesterol is a fat-like organic chemical that is an essential part of animal cell membranes. Without it, cells won't function properly.
Cholesterol is made into bile, which is needed for digesting fats. It is also helps produce the body's natural steroids, including our sex hormones and the vital stress hormone cortisol. Cholesterol ...
Source: Diabetes Self-Management - May 15, 2013 Category: Diabetes Authors: David Spero Source Type: blogs
Will you survive Wheat Belly?
Dietitian Kristi King reviewed Wheat Belly for the Academy of Nutrition and Dietetics (AND), full text here.
Among her comments:
” . . . there is very little guidance as to what are appropriate substitutions during meals, therefore, one who does not review this diet with a registered dietitian could potentially set themselves up for vitamin and mineral deficiencies, such as B vitamins, calcium, and vitamin D just to name a few.”
“Review this diet with a registered dietitian”? Is she serious? This is indeed consistent with the agenda that the Academy has been pursuing for many years, trying to make ...
Source: Wheat Belly Blog - March 23, 2013 Category: Cardiology Authors: Dr. Davis Tags: Wheat Belly counterattacks Source Type: blogs
#182: ACC 2013: Stopping rivaroxaban and warfarin temporarily in AF patients yields similar risks; PREVAIL yanked from ACC program; Watchman device meets safety end point; Niacin full results in HPS2-THRIVE; Another strike for digoxin in AF
ACC 2013: Stopping rivaroxaban and warfarin temporarily in AF patients yields similar risks; PREVAIL yanked from ACC program; Watchman device meets safety end point; Niacin full results in HPS2-THRIVE; Another strike for digoxin in AF (Source: Blogs@theHeart.org)
Source: Blogs@theHeart.org - March 13, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: blogs
Niacin
The results the HPS2-THRIVE trial were presented at the ACC the other day. In this large trial, niacin was shown NOT to prevent major adverse Cardiovascular events any more than placebo. This is despite causing average reductions in LDL of 10 mg/dL and triglycerides of 33 mg/dL, in addition to a 6 mg/dL increase in HDL.
When interpreting a trial like this, it is important to understand the patient population studied. These were patients at high risk that already had LDL < 70mg/dL. This is important to understand. In patients like this, it is clear that niacin does not work. But what about patients who are on statin wi...
Source: Dr Portnay - March 11, 2013 Category: Cardiology Authors: Dr Portnay Source Type: blogs
HPS2-THRIVE: A ‘Disappointing But Clear’ Result
The results of HPS2-THRIVE were “disappointing but clear,” said Jane Armitage, who presented the results this morning at the ACC in San Francisco. HPS2-THRIVE randomized 25,673 high-risk patients who could tolerate niacin to either placebo or extended-release niacin plus laropiprant (Tredaptive, Merck), an anti-flushing agent, in addition to background therapy. The primary endpoint was the time to first major vascular event, defined as the composite of non-fatal MI or coronary death, any stroke or any arterial revascularization. Major vascular events occurred in 13.2% of the niacin arm and 13.7% of the plac...
Source: CardioBrief - March 9, 2013 Category: Cardiology Authors: Larry Husten Tags: People, Places & Events Prevention, Epidemiology & Outcomes High-density lipoprotein HPS2-THRIVE LDL Low-density lipoprotein niacin Source Type: blogs
Niacin
theheart.org is reporting today that The European Medicines Agency (EMA) will be launching a review of all niacin (nicotinic acid) agents. This is due to new data from a soon to be reported trial at the ACC in San Francisco, HPS2-THRIVE. It is being reported that a combination of niacin and another agent (which was supposed to reduce the flushing of niacin) "failed to show that the combination reduces the risk of major vascular events (such as heart attack and stroke), and a higher frequency of non-fatal but serious side effects was seen in patients taking the combination." The EMA is launching the review t...
Source: Dr Portnay - March 8, 2013 Category: Cardiology Authors: Dr Portnay Source Type: blogs
The "Buzz" on ACC.13 Late-Breaking Clinical Trials
This post is authored by Christopher P. Cannon, MD, FACC, is editor-in-chief of CardioSource Science and Quality.
Late-breaking clinical trials (LBCTs) have become the centerpiece of major cardiology scientific sessions. On the upside, they produce significant advances that will reshape the practice of medicine (if and when we ever adopt them), and, more recently, they’ve challenged long-held beliefs about the benefits of various older treatments. On the other hand, they can sometimes lead to disappointment (ie. when a study produces negative findings or is too small to be definitive).
So, LBCTs—are th...
Source: ACC in Touch Blog - March 6, 2013 Category: Cardiology Authors: Administrator Tags: ACC Scientific Session Science Source Type: blogs
#180: "Choosing wisely" now targets over 130 dubious tests, therapies; HPS2-THRIVE: High myopathy risk with niacin/laropiprant; unrestricted Mediterranean diets beat low-fat advice for primary CVD prevention; large proportion of raised LDL cholesterol...
Choosing wisely now targets over 130 dubious tests, therapies; HPS2-THRIVE: High myopathy risk with niacin/laropiprant; unrestricted Mediterranean diets beat low-fat advice for primary CVD prevention; large proportion of raised LDL cholesterol in (Source: Blogs@theHeart.org)
Source: Blogs@theHeart.org - March 1, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: blogs
